China Pharma Holdings - 53 Year Dividend History | CPHI

Historical dividend payout and yield for China Pharma Holdings (CPHI) since 1972. The current TTM dividend payout for China Pharma Holdings (CPHI) as of May 12, 2025 is $0.00. The current dividend yield for China Pharma Holdings as of May 12, 2025 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.007B $0.005B
CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.364B 7.36
Dr Reddy's Laboratories (RDY) India $11.628B 21.11
BridgeBio Pharma (BBIO) United States $6.775B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.800B 14.61
Bausch Health Cos (BHC) Canada $1.732B 1.27
Amphastar Pharmaceuticals (AMPH) United States $1.156B 7.70
Taysha Gene Therapies (TSHA) United States $0.476B 0.00
Personalis (PSNL) United States $0.450B 0.00
Assembly Biosciences (ASMB) United States $0.094B 0.00
Sol-Gel Technologies (SLGL) Israel $0.021B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00